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Abstract We have earlier reported that when a weak 50 Hz MF 
(magnetic field) was applied, the leukemic T-cell line Jurkat 
responded with intracellular calcium oscillations [LindstrOm, et 
al., J. Cell Physiol., 156 (1993) 395-398]. The result suggested 
that the MF interfered with the signal transduction, although 
neither target molecules nor molecular mechanisms are at present 
known. In this study we found that application of a MF to Jurkat 
cells resulted in significant increase of inositol 1,4,5-trisphosphate 
(IP3) levels. Chelation of intracellular calcium ions by BAPTM 
AM, did not block the increase of IP 3 induced by MF. This result 
implied that MF-induced Ca 2+ oscillations were not due to direct 
stimulation of the Ca2+-dependent phospholipase C-~,I (PLC-~/1). 
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1. Introduction 
Low frequency magnetic fields (MF) have been reported to 
affect several basic cellular functions such as growth, differen- 
tiation, macromolecular synthesis and to cause chromosomal 
aberrations [2-9]. Epidemiological studies have implied an in- 
creased risk for malignant umours in individuals exposed to 
MF  [10-13]. Previous studies of effects on intracellular calcium 
have demonstrated effects on Ca 2+ uptake after prolonged ex- 
posure, using 45Ca, which gives an estimation of effects on 
intracellular calcium pools [14,15]. 
No molecular mechanism has been established to explain 
how these biological effects are achieved. In a previous report 
from our laboratory it was shown that an applied sinusoidal 50 
Hz MF  caused oscillatory increases of [Ca2+]~ in the leukemic 
T-cell line Jurkat. The effect was in the same order of magni- 
tude as that caused by stimulation of the CD3 receptor complex 
with an anti-CD3 monoclonal antibody, and occurred within 
minutes after application [1]. These type of changes in [Ca2+]~ 
are typical for an established signalling pathway from cell sur- 
face receptors to the nucleus [16]. 
The regulation of [Ca2+]i in T-cells is receptor-regulated and 
the influx of Ca 2+ through the plasma membrane does not occur 
by classic voltage-dependent calcium channels [17]. Upon T-cell 
receptor stimulation, tyrosine phosphorylation of the PLC-),I 
activates this enzyme, leading to hydrolysis of phosphatidyl- 
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inositol 4,5-biphosphate (IP2) to diaglycerol and IP 3 [18 20]. 
The role of calcium signalling and [Ca2+]~ regulation by IP 3 has 
been extensively reviewed [16]. While it is generally accepted 
that IP 3 releases Ca 2+ from intracellular stores through IP 3- 
activated channels, the mechanisms that regulate the sustained 
Ca 2+ entry across the plasma membrane during the precommit- 
ment period are controversial. The activation of T-cells requires 
prolonged increases in [Ca2+]i, derived from extracellular 
sources [22]. Patch-clamp studies have showed that IP 3 acti- 
vated, in a dose dependent fashion, a Ca2+-permeable channel 
in the plasma membrane of Jurkat cells [23]. Confocal micro- 
scopic studies have further shown that, upon receptor stimula- 
tion and during calcium increase, the IP 3 receptors are located 
close to the TCR [24]. As a result [Ca2÷]~ is increased, both from 
intracellular and extracellular sources, via IP3-sensitive chan- 
nels in the plasma membrane and the endoplasmic reticulum; 
the so-called IP 3 hypothesis [25]. In contrast, the depletion 
hypothesis asserts that IP 3 only liberates Ca 2+ from the endo- 
plasmatic reticulum and that the ensuing depletion of this Ca 2+ 
store generates a second signal that activates Ca 2+ influx [26]. 
The signal in Jurkat cells that couples depletion of stores to 
activation of influx can not be Ca 2+ itself, as patch-clamp- 
measured Ca 2+ currents developed in the presence of the cal- 
cium chelating agent BAPTA before any increase in [Ca2+]i [27]. 
The PLCy-1 activity is thought to be regulated by tyrosine 
phosphorylation upon TCR stimulation [28]. There are also 
other signalling pathways, in addition to the phosphoinositide 
pathway, which may increase [Ca2+]i n these cells [29]. 
We undertook this study to investigate whether a 50 Hz MF  
could affect the levels of IP 3 in the T-cell line Jurkat. Our data 
suggest hat MF  effects signal transduction events upstream of 
release of IP 3. 
2. Materials and methods 
2.1. Exposure system for the IP 3 measurement 
The magnetic field was generated by a pair of Helmholtz' coils with 
20 turns (diameter 20 cm), with the magnetic field in a vertical direction. 
Since only a sinusoidal 50 Itz MF was used the coils were fed from a 
variable transformer connected to the mains. The magnitude of the 
applied field, 0.10 mT, was set by monitoring the current in the coils 
on an amperemeter, connected inseries with the coils and then calculat- 
ing the field, and by measuring with a small, calibrated, pick-up coil. 
The sham and the exposure coils were placed inside Forma incubators, 
modified to give low stray MF below 0.2 pT. No attempt was made to 
control the geomagnetic field, which was measured with a Bell Gauss 
meter. The values for the exposure incubator were 17 ,uT for the total 
geomagnetic field and 14 pT for the vertical component. The corre- 
sponding values for the sham exposure incubator were 35 and 22 pT, 
respectively. 
Temperature (37°C) was the same in the incubators both for exposed 
and sham exposed cells. 
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2.2. Exposure system for the intracellular calcium measurements 
A homogenous vertical magnetic field was set up by using a pair of 
Helmholtz coils supplied from the mains via a low voltage transformer 
[1]. The total geomagnetic field was 62 ¢tT with a vertical component 
of 55 ,uT. The applied vertical sinusoidal 50 Hz field was 0.15 mT. 
Environmental stray fields were controlled as well as the temperature 
(37°C) in the chamber. 
2.3. Cells and chemicals 
The leukemic T cell line Jurkat was grown in RPM1 1640 medium 
containing 10% FCS, 100 U/ml penicillin and 100/.tg/ml streptomycin. 
The monoclonal antibody (MAb) UCHT-1, specific for the CD3 recep- 
tor is available from DAKO A/S; BAPTA/AM was purchased from 
Calbiochem and ionomycin from Sigma. 
2.4. Measurement of  intracellular free eytosolic Ca: + 
Cells were put on cover glasses coated with poly-L-lysine solution 
(0.01%) and incubated in an CO2 incubator for 60 min at 37°C, with 
fura-2/AM at 2 ,uM [30,31]. 
2.5. Measurement of  lP  s in Jurkat cells 
The cell concentration was adjusted to approximately 10~'/ml. Cells 
were collected at different ime points, as indicated in the figures (Figs. 
2~,), in 0.4 or 0.5 ml aliquots after the different reatments. IP3 was 
assayed using a commercially available kit (Amersham InternationalL 
The assay is based on competition between unlabelled and tritium- 
labelled IP3 for binding sites on a bovine adrenal binding protein prep- 
aration. The data represent the mean of several experiments as indi- 
cated in figure legends. 
2.6. Chelation of  intracellular free Ca :+ 
Jurkat cells were pretreated by adding BAPTA/AM to incubation 
media for 30 min before exposure to MF. Different BAPTA/AM con- 
centrations were tested by fura-2 measurements to find the optimum 
that completely blocked Ca 2+ oscillations induced by MF (Fig. IA,BI. 
As a positive control for increase of [Ca2+]~ we used addition of the 
anti-CD3 antibody UCHT-1, or the calcium ionophor, ionomycin, as 
previously described [1]. 
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Fig. 1. Measurements of [Ca2÷]~ in single cells after 30 min pretreatment 
with 37 ¢tM (A) or 75/IM (B) BAPTA/AM. At the times indicated, anti- 
CD3 (0.5/lg/ml) and ionomycin (1 pg/ml) was added. The traces are 
representative of seven experiments. 
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Fig. 2. Levels of IP 3 in lysates of Jurkat cells exposed to MF (50 Hz, 
0.10 mT), the anti-CD3 MAb UCTH-1 (0.5 mg/ml), or to both stimuli. 
The figure represents the mean of six experiments, m, sham exposed 
control; o, anti-CD-3 MAb; A, 50 Hz, 0.10 mT; v, 50 Hz, 0.10 
mT+ anti-CD3 MAb. S.E.M. was < 30%. 
3. Results 
Jurkat cells were exposed to MF  (50 Hz, 0.1 mT) and samples 
for determination of IP 3 levels were taken during the first 10 
rain as indicated in Fig. 2. An optimised concentrat ion of the 
anti-CD3 monoclonal  ant ibody was used as a positive control, 
as upon binding to the CD3 complex it initiates a signalling 
cascade through the phosphatidyl inositol  pathway, resulting in 
[Ca2+]i oscillations [1,32]. 
In repeated experiments the level of intracellular IP 3 in- 
creased almost immediately after application of MF, with a 
maximum at 2 min. The magnitude of the increase was the same 
as that for the anti-CD3 MAb,  which, however, peaked at 6 
min. The combinat ion of the monoclonal  ant ibody and MF 
gave an additive effect after 2 and 6 min of treatment. However, 
the combined treatment seemed to give a synergistic effect after 
1 rain. 
Pretreatment with the cytosolic calcium chelator BAPTA/ 
AM resulted in an initial lower [Ca2+]i of 40-50 nM, compared 
to untreated Jurkat cells that have a base level of 50-100 nM. 
Almost all intracellular calcium was bound using a BAPTA/ 
AM concentrat ion of 37/.tM (Fig. 1A). Ant i -CD3 MAb binds 
to the TCR complex, and is a well-known stimulator of the 
phosphatidyl inositol pathway and the second messenger Ca 2+ 
[18]. Addit ion of anti -CD3 in BAPTA-loaded cells could not 
increase the [Ca2+]i . Ionomycin, that normally rapidly increases 
intracellular calcium levels, had no effect. As much as 75 ¢tM 
BAPTA/AM resulted in extremely low basal [Ca2+]i, approxi- 
mately zero values (Fig. 1B). Neither MF  nor  ionomycin could 
overcome this strong BAPTA-chelation during the measure- 
ments. 
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As the MF could still induce an increase of IP3 in the pres- 
ence of high concentrations of BAPTA/AM (Fig. 3), we con- 
cluded that the applied MF induced an increase in IP3 inde- 
pendent of increases of the [Ca2+]i levels. Ionomycin treatment 
resulted in a prompt increase in the levels of IP3 already after 
30 s, and high levels of IP 3 were maintained for 6 min (Fig. 4). 
These results uggests that the applied MF interferes with the 
receptor-triggered signal transduction pathway, which results 
in release of intracellular [Ca2+]i, and that the target for MF is 
PLC-yl, or molecules upstream of that enzyme, and not cal- 
cium channel interactions. 
4. Discussion 
Cells of the immune system have been shown to be respon- 
sive to MF as discussed by Walleczek [2]. Cellular esponses to 
MF of the type applied in our study have been hypothesised to
be due to interactions with molecules in the cell membrane, 
although they have not been identified. 
In a previous publication it was shown that MF increased 
[Ca2+]i in a similar pattern, both in respect o amplitude and 
oscillation [1]. Here we provide data that the observed transient 
increases in free intracellular Ca 2+ might be a consequence of 
activation of PLC-yl. The role of this enzyme in cellular sig- 
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Fig. 3. Levels of IP3 in lysates of Jurkat cells exposed uring indicated 
times to the Ca 2+ chelator BAPTA/AM (50 pM) and MF (50 Hz, 0.10 
mT). The figure represents he mean of three experiments. 
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Fig. 4. Levels of IP 3 in lysates of Jurkat cells exposed to MF (50 Hz, 
0.10 mT), the anti-CD3 monoclonal antibody and ionomycin. The 
figure represents the mean of four experiments, m  sham exposed con- 
trol; e, ionomycin 4/.tg/ml; A, 50 Hz, 0.10 mT. Standard errors of the 
mean were < 30%. 
nailing in T lymphocytes is well established [18]. The amplitude 
of the IP3 increase was of the same order as that caused by the 
addition of anti-CD3 antibodies, and the time course fits with 
the observed start of [Ca2+]~ oscillations [1]. 
It is known that all phopholipases are activated by calcium 
[17], and the observed [Ca2+]i increase due to MF exposure may 
just as well be the result of e.g. unspecified membrane effects, 
causing leakage of extracellular Ca 2+ into the cells. However, 
our results showed increased IP3 levels even when all the cy- 
tosolic free Ca 2+ was chelated by BAPTA (Figs. 1 and 3). We 
therefore think that it is not an unspecific increase of Ca 2+ that 
activates PLC-yl and results in the IP3 increase. Increased IP 3 
levels upon stimulation with anti-CD3 or phytohaemagglutinin 
in BAPTA-loaded Jurkat cells has been reported by others [33]. 
The fact that also the Ca2+-ionophore, ionomycin, caused an 
increase of IP 3 might support he notion that IP3 is generated 
rather by an increased [Ca2+]~ than the reverse, or that ionomy- 
cin has effects other than just to open calcium channels. Since 
the calcium chelator BAPTA/AM did not inhibit the IP3 in- 
crease upon MF exposure, and the kinetic and the level of IP 3 
increase resemble the anti-CD3 stimulation, our data suggest 
that the applied MF interferes with events upstream of PLC-y 1. 
This is further supported by ongoing experiments indicating the 
need for CD45 expression for MF-mediated calcium oscilla- 
tions. The validity of the findings in this report and its biolog- 
ical significance can only be revealed by further studies of the 
early signal pathway events, upstream of the observed effects 
on IP 3 and [Ca2+]i levels. 
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